ASCO Backs Routine ESR1 Testing for Certain Breast Cancers
Activity of elacestrant in EMERALD trial 'provides strong signal' for guideline update
Stay updated with breaking news from Rapid Recommendation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Activity of elacestrant in EMERALD trial 'provides strong signal' for guideline update
According to an international team of experts, additional cholesterol-lowering drugs should be offered to patients with bad cholesterol (LDL) levels (70 mg/dl or more) and those at high risk of heart disease.
Get latest articles and stories on Health at LatestLY. According to an international team of experts, additional cholesterol-lowering drugs should be offered to patients with "bad" cholesterol (LDL) levels (70 mg/dl or more) and those at high risk of heart disease. Health News | Experts Recommend Additional Cholesterol-lowering Medications for Adults at High Risk of Heart Disease.